A phase I/IIa trial of the RNA oligonucleotide STNM01 by EUS-FNI to investigate the safety and efficacy in patients with first-line refractory, unresectable pancreatic cancer Meeting Abstract
| Authors: | Tsuchiya, T.; Fujisawa, T.; Kato, M.; Mizuide, M.; Torisu, Y.; Nishimura, M.; Kurosawa, T.; Tomishima, K.; Takakura, K.; Kutsumi, H.; Matsuda, Y.; Arai, T.; Saya, H.; Ryozawa, S.; Isayama, H.; Itoi, T.; Yahagi, N. |
| Abstract Title: | A phase I/IIa trial of the RNA oligonucleotide STNM01 by EUS-FNI to investigate the safety and efficacy in patients with first-line refractory, unresectable pancreatic cancer |
| Meeting Title: | 2021 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 39 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2021 Jun 4-8 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2021-05-20 |
| Language: | English |
| ACCESSION: | WOS:000708120602220 |
| DOI: | 10.1200/JCO.2021.39.15_suppl.4120 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 4120 -- Source: Wos |
